Content of the article continued
Vaccine hopes rise as Oxford jab triggers immune response in older and young adults
One of the world’s leading experimental COVID-19 vaccines is producing an immune response in young and old adults, raising hopes of a way out of the gloom and economic destruction caused by the novel coronavirus.
The vaccine, developed by the University of Oxford, also triggers weaker adverse reactions in the elderly, UK drug maker AstraZeneca Plc, which helps manufacture the vaccine, said on Monday.
A vaccine that works is seen as a game changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, shut down swathes of the global economy and disrupted the normal lives of billions of people.
Vote to examine Liberal response to COVID-19 highlights clash between politics and science
Monday’s vote on a Conservative motion to launch a comprehensive review of the Liberal government’s response to COVID-19 highlights a major pandemic policy challenge: how to hold a government accountable for science-based decisions, as the science itself changes almost every day.
The opposition wants a committee to investigate everything from reasons regulators take so long to approve rapid tests to a quick decision not to close the border to international travel, and what the Liberals are concerned about is the way this survey is framed.
“One of the stories I find most distressing coming from the opposition is that somehow, because opinions changed at some point that the government was hiding information or that the government was giving out disinformation, ”Health Minister Patty Hajdu said late last week.